Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+2.31M
-
Total reported value, excl. options
-
$2.48B
-
Value change
-
+$300M
-
Put/Call ratio
-
0.37
-
Number of buys
-
119
-
Number of sells
-
-92
-
Price
-
$146.04
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q3 2023
276 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q3 2023.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
of 22.2M outstanding shares and own 76.5% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.04M shares), VANGUARD GROUP INC (1.57M shares), Avoro Capital Advisors LLC (1.56M shares), BAKER BROS. ADVISORS LP (1.55M shares), BlackRock Inc. (1.03M shares), STATE STREET CORP (642K shares), PAULSON & CO. INC. (500K shares), FMR LLC (440K shares), MARSHALL WACE, LLP (395K shares), and ALLIANCEBERNSTEIN L.P. (361K shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.